Sector updates in November

< 1 minute read

Investment firms

  • Sofinnova Partners successfully closes its latest flagship fund, Sofinnova Capital XI, with €650 million to back a new generation of pioneering biopharmaceutical and medical technology companies addressing urgent unmet clinical needs
  • Medicxi successfully closes its sixth fund, Medicxi V, with €500 million dedicated to building and backing innovative biotechnology companies with clear product visions to transform patient care.
  • Forbion successfully closes its €200 million BioEconomy Fund I to target investments at the nexus of biotechnology and planetary health
  • United Founders, a new pre-seed and seed stage fund, launches with a successful close of €30 million. The fund will back deeptech and emerging tech startups
  • Philip Brainin left his role as Associate at Sound Bioventures
  • Khatereh Ahmadi appointed Venture Partner at XGEN Venture

Analysts/Banking/ Associations

  • Arnaldo De Lisio appointed Managing Partner at Catalyst Advisors
  • Daniel Parisotto appointed Co-Head of Healthcare Investment Banking at Societe Generale

Media 

  • Aanu Adeoye appointed acting Global Pharmaceuticals Correspondent, covering Hannah Kuchler’s maternity leave at the Financial Times
  • Kai Nicol-Schwarz, previously Senior Reporter at Sifted, appointed Reporter and CNBC
  • Nathan Ni left his role as Senior Science Editor at The Scientist
  • Rob Coker left his role as Deputy Editor at Medicine Maker
  • Rebecca Forand left her role as Executive Editor at Healio
  • Shawn Zeller appointed Healthcare Editor at POLITICO (US)
  • Erin Schumaker appointed Health Care Editor at POLITICO (US)
  • Madeleine Varner appointed Senior Writer at WIRED US
  • Susanna Galton promoted to Senior Health Features Writer at The Daily Telegraph
  • Charlotte Moore left her role as Head of Health, Features at The Daily Telegraph and appointed Editor of Femail at the Daily Mail
  • Wiliam Hunter appointed Senior Technology & Science Reporter at The Daily Mail online